Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANKMY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AFDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ROPN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NANOG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130950 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DQB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC102723448 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XAGE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105378052 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FHL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL27A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on